The incorporation of the wholly owned subsidiary is intended to expand both the Business-to-Consumer (B2C) and Business-to-Business (B2B) customer segments and to provide greater access to the medical device business.

Upon incorporation, the proposed company will become a step-down subsidiary of Morepen Laboratories.